SII 2012.12
Transcript of SII 2012.12
-
8/16/2019 SII 2012.12
1/10
In one of our earliest issues of Value
Investor Insight [May 22, 2005] we
wrote about the challenge investors
face in marrying confidence with humility:
There's no question that confidence in
one's investing abilities is a prerequisite tosuccessful investing. To commit your own
and others' hard-earned capital requires
conviction, and conviction requires confi-
dence. But as with fine scotch or pepper-
oni pizza, too much of a good thing can
cause problems. The market can be unfor-
giving when over-confidence results in too
much trading, sloppy analysis, lack of fol-
low-through and excessive risk-taking.
How difficult it is to walk the line
between sticking to your guns and recogniz-
ing when you may be wrong hit home againfollowing Bill Miller's announcement earli-
er this month that he was stepping down as
manager of the Legg Mason Value Trust
mutual fund that made him famous. Much
of the commentary that ensued focused on
Miller's first misreading the depths of the
housing downturn in 2007 and then way
overstaying his welcome with financials in
2008. As Miller himself told The Wall Street
Journal , “Our philosophy has always been
to go in and buy the disrupted sector, but it
didn't work the last time.”As were Miller's in 2007 and 2008,
investors' convictions are challenged all the
time. A cycle appears to turn sooner or later
than expected. A restructuring plan is modi-
fied or doesn't seem to be working. A com-
petitive threat comes out of the blue. While
we can certainly attest to the fact that suc-
cessful investors don't lack self-confidence
and strong conviction, we'd also argue that
what often sets them apart is a constant
search for disconfirming evidence and a will-
ingness to recognize errors in judgment andrespond accordingly. A typical example:
After buying Yahoo stock in the first quarter
in part because of hidden value it saw in the
company's stake in China's Alibaba Group,
David Einhorn's Greenlight Capital sold its
shares the following quarter when a dispute
arose over the ownership of some of
Alibaba's assets. Explained Einhorn simply:
“This wasn't what we signed up for.”
While such flexibility is key, it’s proba-
bly not the most important weapon against
the potential damage of hubris. More criti-cal is Ben Graham’s concept of investing
with a margin of safety, which he described
as being “available for absorbing the effect
of miscalculations or worse than average
luck” – both of which unfortunately seem
to be in ample supply. SII
I N T H I S I S S U E
What They’re Buying
Last quarter offered many market-tanking types of ideas on which topinvestors pounced, from tech titansto once-proud outcasts. Page 2
Table: Coming Into RangeTable: Biggest New Bets
What They’re Selling
SuperInvestor selling last quarterfocused more on swapping one
idea for a better one than on exit-ing big winners or losers. Page 4Table: Middle Innings?Table: Selling Out
What They Own
Star investors’ attitude toward tech-nology and financials has diverged,but both remain well represented inquarter’s-end portfolios. Page 6
Table: Wisdom of CrowdsTable: Top Holdings
Stock Spotlight: HCA HoldingsAvid SuperInvestor interest lastquarter in this hospital operatorwould indicate they rememberleverage works both ways. Page 8
INSIGHTSuperInvestor
From the Editors of Value Investor Insight
U P F RO NT
SuperInvestor Insight tracks the activityof an elite group of value-orientedhedge-fund managers (plus BerkshireHathaway), based on their holdings as
filed in Forms 13F with the SEC. Whilespecific investors will be highlighted,the focus is on drawing collectiveinsight from this group of 30 of theworld’s best investors, which currentlyincludes William Ackman, LeonCooperman, David Einhorn, GlennGreenberg, John Griffin, Carl Icahn,Seth Klarman, Stephen Mandel,John Paulson, David Tepper, JeffreyUbben and many more.
The SuperInvestors
Confidence Game
December 2, 201
John HeinsCo-Editor-in-Chief
Whitney TilsonCo-Editor-in-Chief
-
8/16/2019 SII 2012.12
2/10
SuperInvestor Insight 2December 2, 2011 www.superinvestorinsight.com
Lying in WaitStocks get cheap enough for SuperInvestors to buy for a variety of recurring reasons, many of which were well
in evidence in the third quarter as the market’s swoon took the shares of good company and bad down with it.
The specifics vary widely, but the rea-
sons most value investors give for why a
given stock gets cheap enough for them to
buy usually fall into a few broad cate-
gories: the overall market is tanking, the
relevant sector is cyclically down or out-
of-favor, the company is undergoing sig-
nificant change that is misunderstood or
unappreciated, or something bad happens
on the earnings front or otherwise to
shake investor confidence.
This year's third quarter offered up
several market-tanking types of ideas of which SuperInvestors appear to have
taken advantage (see table below). From
its high for the quarter on July 7th, the
S&P 500 within a month had fallen near-
ly 20%, taking the shares of good compa-
ny and bad down with it. This likely
explains why so many top investors
increased their positions or added new
ones in tech titans Google and Apple,
whose stock prices swooned while operat-
ing results continued to impress. It also
helps explain the aggressive buying in
deep-moat credit card company Visa,
whose business Thomas Russo extolledwhile speaking of competitor MasterCard
in the latest Value Investor Insigh
[November 29, 2011]: “[These are] heav
ily branded consumer products that have
extraordinary potential globally due to
the substitution of commerce for subsis
tence, and the migration within commerce
toward payment systems other than cash
This is also a case where I believe the busi-
ness is enhanced rather than threatened by
technology, resulting in innovative ways
to pay by credit that will hasten the shift
away from paying by cash.”
There was specific negative news aswell to augment share declines during the
W HAT T H EY ’ RE B U Y I NG
Company Ticker IndustryPrice@12/1/11
Q3 2011 # of New orInc. Positions
% Change In SharesHeld - All FundsLow High
Google GOOG Internet Services 613.77 490.86 627.50 9 45.1%
Apple AAPL Computers/Consumer Electronics 387.93 334.20 422.86 6 16.2%
CVS Caremark CVS Pharmacy Services 38.48 31.30 38.82 6 (-12.3%)
HCA Holdings HCA Hospitals 24.19 17.03 34.92 6 88.6%
News Corp. NWSA Media/Entertainment 17.56 13.38 18.20 6 86.8%
Williams WMB Oil & Gas 32.41 23.46 33.16 6 112.2%
Citigroup C Banking 26.99 23.19 43.06 5 (-9.9%)
Seagate Technology STX Computer Storage Devices 17.40 9.96 17.17 5 (-24.8%)
Visa V Credit Cards 97.76 76.11 94.75 5 445.7%
Wells Fargo WFC Banking 25.64 22.58 29.63 5 0.5%
American Tower AMT Wireless Infrastructure 58.60 46.04 56.21 4 (-6.4%)
Coca-Cola Enterprises CCE Beverage Distribution 25.81 23.97 29.99 4 58.2%
Comcast CMCSA Cable Services 22.57 19.19 26.14 4 (-34.8%)
Express Scripts ESRX Pharmacy Services 46.50 37.06 57.47 4 51.0%
General Motors GM Automobiles 20.96 19.77 32.08 4 76.1%
Home Depot HD Home-Improvement Retail 39.34 28.13 37.25 4 (-48.3%)
Life Technologies LIFE Medical Products 39.17 35.30 52.61 4 15.4%
Sprint Nextel S Wireless Services 2.70 2.95 5.75 4 34.0%
Four or more SuperInvestors added to existing positions or established new ones worth at least$20 million in these stocks last quarter. Technology powerhouses Google and Apple were quitepopular, as were once-proud outcasts such as News Corp., General Motors and Sprint Nextel.
What They’re Buying:Coming Into Range
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
3/10
SuperInvestor Insight 3December 2, 2011 www.superinvestorinsight.com
quarter. Media giant News Corp. made
the most-bought list for the second quar-
ter in a row – with six investors adding to
positions – as the company's public-rela-
tions nightmare over sleazy and potential-
ly illegal reporting practices in the U.K.
resulted in high-level management depar-
tures and called into question the stew-
ardship of those who remained. The
impact on the company's business has
been minimal, however, and the stock has
rebounded, trading today at around
$17.60, up 30% from its Q3 low.
The bad news has been more tangible
for wireless service provider Sprint
Nextel, which attracted bottom-fishing
buying interest from four star investors
last quarter. The company reported weak
earnings as a result of phone-subsidyspending to drive customer acquisition. It
announced higher-than-expected capital
spending needs and then bungled badly
its explanation for how it would pay for
it. Even the announcement that it would
start selling Apple's iPhone was met with
criticism over the profitability of the
effort. David Einhorn of SuperInvestor
Greenlight Capital – which upped its
Sprint share stake by one-third in the
quarter – offered this critical assessment
of the company in his latest investor let-
ter: “Management is on the verge of los-
ing the confidence of the financial mar-
kets. We believe the business opportunity
and asset values remain sufficient to justi-
fy holding the shares, and we wouldn't be
surprised if shareholders begin to agitate
for significant strategic change. Given the
heavy need to invest, the opportunity may
be better pursued by a new owner with a
lower cost of capital.”
While healthcare stocks were absent
from the previous quarter’s most-bought
list, top-investor interest in the sectorpicked up last quarter with active buying
in CVS Caremark, HCA Holdings,
Express Scripts and Life Technologies.
Hospital owner HCA appeared very much
the “busted” IPO during the quarter, as its
shares fell as much as 40% from a March
initial offering price of $30 due to genera
economic concerns and fears that U.S
debt discussions would result in even
greater healthcare spending restrictions
Though off their lows, at a recent $24.20
the shares trade today at only 7x consen
sus 2012 earnings estimates. (For more on
HCA, see Stock Spotlight, p. 8.)
In addition to Silicon Valley addresses
and less-than-stellar performance, Yahoo
and Hewlett-Packard shared two other
distinctions during the quarter. The first
was that they were among the biggest
new buys by individual SuperInvestors
(see table below), as Third Point LLC
bought Yahoo shares worth $632 million
at quarter's end and Baupost Group initi
ated an H-P position worth $466 million
The final shared trait: Both companiesunceremoniously dumped their CEOs in
September. We'll assume the investors in
either case were not surprised.
Funds co-managed by Whitney Tilson are long
C, STX and WFC.
SII
W HAT T H EY ’ RE B U Y I NG
Company Ticker Industry Price@12/1/11
Q3 2011 Investor Price Vs.Q3 2011 HighLow High
El Paso EP Oil & Gas 25.04 16.64 21.18 Icahn 18.2%
Yahoo YHOO Internet Services 16.23 11.09 15.95 Third Point 1.8%
Hewlett-Packard HPQ Computer Equipment/Services 28.22 21.50 37.70 Baupost (-25.1%)
News Corp. NWSA Media/Entertainment 17.56 13.38 18.20 Highfields (-3.5%)
Apple AAPL Computers/Consumer Electronics 387.93 334.20 422.86 Viking (-8.3%)
Lowe’s LOW Home-Improvement Retail 23.87 18.07 24.21 Pershing Square (-1.4%)
Las Vegas Sands LVS Gaming 46.69 36.08 50.49 Lone Pine (-7.5%)
Marvell Technology MRVL Semiconductors 13.86 11.23 15.93 Greenlight (-13.0%)News Corp. NWSA Media/Entertainment 17.56 13.38 18.20 Paulson (-3.5%)
Intel INTC Semiconductors 24.92 19.16 23.39 Berkshire Hathaway 6.5%
Family Dollar Stores FDO Discount Retail 59.06 44.42 55.89 Scout 5.7%
Owens-Illinois OI Glass Containers 19.51 15.11 27.07 Farallon (-27.9%)
Freeport-McMoRan FCX Metals/Mining 39.28 30.37 56.78 Relational (-30.8%)
Family Dollar Stores FDO Discount Retail 59.06 44.42 55.89 Pennant 5.7%
Lockheed Martin LMT Defense 78.98 66.36 82.23 Karsch (-4.0%)
These are the 15 largest brand-new positions taken by different SuperInvestors last quarter. Twoinvestors each made significant wagers on News Corp. and Family Dollar Stores. Those currentlytrading the furthest from their Q3 highs: Freeport-McMoRan, Owens-Illinois and Hewlett-Packard.
What They’re Buying:Biggest New Bets
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
4/10
Swap MeetFew big winners or glaring errors stand out among stocks sold last quarter by SuperInvestors. The more likely
selling rationale: swapping out of “middle-innings” opportunities and into those closer to the start of the game.
When asked why SuperInvestor Scout
Capital had sold two core holdings –
Verisk Analytics and Coca-Cola
Enterprises – in this year's first quarter
after he and co-portfolio manager James
Crichton had articulated the detailed bull
cases for each a few months earlier in
Value Investor Insight (December 2,
2010), Adam Weiss offered a clear
description of how Scout thinks about
selling: “There is nothing negative we'd
say about either company. Sometimes we
sell when we've been right, sometimes wesell when we've been wrong, and some-
times we sell because there are four more
things that became more compelling.
That is what happened here. There's a
common expectation that people who do
primary research in the depth we do to
arrive at their own fundamental view of
what value is over a three- to five-year
time horizon should hold the stocks for
that long. That can happen, but the reali-
ty is it often doesn't work out that way. I
would stress that we could get back into
either of them at any time, but when we
looked at our portfolio during the first
quarter, we felt we had other, fresher
ideas more in the early innings of the
market's misunderstanding than the mid-
dle innings, and we will consistently make
that swap.”This description would appear to
explain the rationale behind many of the
stocks most frequently sold by
SuperInvestors in the third quarter (see
table below). Few big winners or glaring
errors stand out, but the stretching out of
time horizons for value to be realized in
many names likely prompted movemen
into “earlier-inning” stocks as the overal
market fell. Enthusiasm for asset manag
er BlackRock, for example, proved short
lived as five investors sharply reduced
their positions, three of which were sold
out entirely. Already the largest asse
manager in the world with more than
$3.3 trillion in assets, the company wil
struggle to show exciting profit growth as
long as investor fear levels remain high
and if lower-margin passively managedfunds – now more than half of the com-
pany's assets – continue to make up a
higher percentage of the total.
After piling into fertilizer company
Mosaic in the previous quarter, star
investors piled out of it last quarter
W H AT T H E Y’ R E S E L L IN G
Company Ticker Industry Price@12/1/11
Q3 2011 # of Decreased orClosed Positions
% Change In SharesHeld - All FundsLow High
Apple AAPL Computers/Consumer Electronics 387.93 334.20 422.86 6 16.2%
JPMorgan Chase JPM Banking 30.46 28.53 42.55 6 (-48.9%)
UnitedHealth UNH Health Insurance 48.52 41.27 53.50 6 (-34.1%)
BlackRock BLK Asset Management 167.41 140.22 199.10 5 (-60.3%)
Citigroup C Banking 26.99 23.19 43.06 5 (-9.9%)
eBay EBAY Online Retail 29.68 26.86 34.99 5 (-5.2%)
SPDR Gold Trust GLD Gold ETF 169.63 143.97 185.85 5 (-35.7%)
Teva Pharmaceutical TEVA Pharmaceuticals 39.74 35.00 49.72 5 (-85.5%)
Aon AON Insurance Brokerage 45.87 39.68 52.17 4 (-16.8%)
Microsoft MSFT Computer Software/Services 25.28 23.79 28.15 4 (-27.9%)
Mosaic MOS Fertilizer 52.77 48.49 74.31 4 (-62.7%)
Pfizer PFE Pharmaceuticals 20.03 16.63 20.95 4 (-86.2%)
Potash POT Fertilizer 43.51 43.06 62.60 4 (-44.7%)
Viacom VIA Media/Entertainment 51.87 47.86 59.45 4 (-45.6%)
WellPoint WLP Health Insurance 70.08 56.61 80.90 4 (-23.4%)
Four or more SuperInvestors reduced or eliminated positions in these stocks during the thirdquarter. Selling often came in sector pairs, including fertilizer companies Mosaic and Potash,managed-care firms UnitedHealth and WellPoint, and pharmaceutical stalwarts Pfizer and Teva.
What They’re Selling:Middle Innings?
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
SuperInvestor Insight 4December 2, 2011 www.superinvestorinsight.com
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
5/10
SuperInvestor Insight 5December 2, 2011 www.superinvestorinsight.com
which they did as well from competitor
Potash. Both companies' shares per-
formed admirably through mid-
September when – as highly cyclical
stocks often do – they fell even more
sharply than the tanking market due to
global macroeconomic fears rather than
any company-specific news. With the
long-term demand case for fertilizer
intact – due to declining global arable
land per person coupled with a growing
appetite and ability to pay in the develop-
ing world for more and better food – it
wouldn't be a surprise to see either stock
back in the good graces of top investors
when they turn more offensively minded.
The most aggressive selling during the
quarter was reserved for pharmaceutical
companies Teva Pharmaceutical andPfizer. Teva has successfully expanded
through acquisition and R&D from its
traditional generic-drug roots to also
owning a lucrative global portfolio of
branded pharmaceuticals, including lead-
ing multiple sclerosis drug Copaxone. Its
shares have performed poorly over the
past year, however, burdened by weak
U.S. generic sales, concerns over generic
competition for Copaxone and setbacks
in both its generic and innovative drug
pipelines. While such ups and downs are
relatively common for a company like
Teva, four of the five SuperInvestors
holding it at the beginning of the quarter
chose not to ride this latest wave and sold
their positions entirely.
One clear big winner that has finally
come in for frequent selling among star
investors: SPDR Gold Trust. The gold
ETF has been a long-time favorite of the
smart-money crowd, but five investorschose to take at least some profits in it
last quarter. There are likely plenty of
profits to be had, as GLD's stock chart
has risen upward in almost uninterrupted
fashion since its launch in November
2004, rising an average annualized 21%
since then.
Among the largest individual sales las
quarter (see table below), Paulson &
Co.'s exit from its large Comcast stake
stands out for going against the grain
Paulson was the only seller of the cable
services giant, while five other top
investors increased their stakes.
In the turbulent market since the end
of the third quarter, three other large sales
– Scout's sale of McDonald's, Lone Pine's
exit from O'Reilly Automotive and
Icahn's sale of Lions Gate Entertainmen
– stand out for another reason: each has
continued to prosper and reach multi
year share-price highs.
Funds co-managed by Whitney Tilson are long
C, JPM and MSFT.
SII
W H AT T H E Y’ R E S E L L IN G
Company Ticker IndustryPrice@12/1/11
Q3 2011Investor
Value @ 6/30($mil)Low High
L-3 Communications LLL Defense 66.01 58.30 88.55 Relational $555.1
Comcast CMCSA Cable Services 22.57 19.19 26.14 Paulson $514.4
Pfizer PFE Pharmaceuticals 20.03 16.63 20.95 Greenlight $483.2
JPMorgan Chase JPM Banking 30.46 28.53 42.55 Viking $390.5
O’Reilly Automotive ORLY Automotive Parts/Supply 77.70 56.25 72.00 Lone Pine $364.5
Microsoft MSFT Computer Software/Services 25.28 23.79 28.15 Ivory $302.8
Pfizer PFE Pharmaceuticals 20.03 16.63 20.95 Appaloosa $298.6
Citrix Systems CTXS Computer Software/Services 71.35 50.21 84.00 Blue Ridge $245.2
Lions Gate Entertainment LGF Media/Entertainment 8.42 6.17 7.58 Icahn $236.4
Aetna AET Health Insurance 41.68 34.50 45.39 Glenview $231.2
Marathon Oil MRO Oil & Gas 27.72 21.58 34.97 Karsch $210.6
McDonald’s MCD Fast-Food Restaurants 95.50 82.01 91.22 Scout $194.8
Charles River Labs CRL Medical Services/Supplies 28.46 27.76 42.20 Jana $167.0
Teva Pharmaceutical TEVA Pharmaceuticals 39.74 35.00 49.72 Omega $162.1
Alere ALR Medical Diagnostics 23.60 19.62 38.53 ValueAct $156.0
These 15 stocks were the largest positions eliminated by different SuperInvestors last quarter.Paulson’s exit from otherwise popular Comcast most went against the grain. Those on which thetrigger appears to have been pulled too soon: O’Reilly Automotive, Lions Gate and McDonald’s.
What They’re Selling:Selling Out
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
6/10
SuperInvestor Insight 6December 2, 2011 www.superinvestorinsight.com
Something Bold, Something BlueWhile SuperInvestors generally have been actively buying technology and actively selling financials so far this
year, both sectors are well represented among the most widely held stocks at the end of the third quarter.
Holding the shares of banks and other
financial institutions has certainly been
no picnic in 2011. While the overall mar-
ket is more or less flat, Vanguard's
Financials ETF is down 17% while large
money-center banks have fared much
worse – Bank of America’s stock, for
example, is off nearly 60%. While they've
been abandoning B of A and have gener-
ally been far more likely to sell financials
than buy them this year, SuperInvestors
did remain large holders of giant bank
holding companies such as Citigroup,Wells Fargo and JPMorgan Chase at the
end of the third quarter (see table below).
Gardner Russo & Gardner's Thomas
Russo described the investment case for
Wells Fargo in the latest issue of Value
Investor Insight (November 29, 2011) as
a bet on far higher earnings power in the
next couple of years as integration
expenses from its Wachovia acquisition
go away, troubled real estate loan portfo-
lios slowly mend, and the yield curve that
has pressured net interest margins eventu-
ally turns more normal. At a recent
$25.65, Wells' shares trade at only
around 6x the $4-plus per share Russo
believes the company can earn in 2014.
Pershing Square Capital's latest quar-
terly investor letter summarizes its thesis
for Citigroup, which was owned by tentop investors at quarter's end: “As the
macro environment has weakened and
worries over the fiscal situation in Europe
have increased, the entire large-cap finan-
cial sector, including Citi, has experienced
material share price declines. During this
period, Citi's business performance has
been solid and its valuation has become
more compelling. Citi trades at 60% o
tangible book value, at about eight times
the depressed level of current earnings per
share of its ongoing CitiCorp core busi
ness, and about three times our estimate
of normalized earnings per share, after
giving credit for the value of excess capi
tal, tax, and other assets.” Potential cata
lysts to the upside, the letter goes on to
say, include progress toward a resolution
of the European debt crisis and Citi's“on-track” efforts to increasingly return
capital to shareholders starting next year
While energy has not attracted avid
top-investor buying interest in recent
quarters, both Williams and BP were
among the most widely held stocks as o
W HAT T HE Y OW N
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
Company Ticker Industry Price@12/1/11
52-Week # of PortfoliosThat Own
Price vs.52-Week HighLow High
Apple AAPL Computers/Consumer Electronics 387.93 310.50 426.70 12 (-9.1%)
Citigroup C Banking 26.99 21.40 51.50 10 (-47.6%)
Google GOOG Internet Services 613.77 473.02 642.96 10 (-4.5%)
CVS Caremark CVS Pharmacy Services 38.48 31.30 39.50 9 (-2.6%)
eBay EBAY Online Retail 29.68 26.86 35.35 8 (-16.0%)
News Corp. NWSA Media/Entertainment 17.56 13.38 18.35 8 (-4.3%)
Wells Fargo WFC Banking 25.64 22.58 34.25 8 (-25.1%)
Williams WMB Oil & Gas 32.41 21.90 33.47 7 (-3.2%)
BP BP Oil & Gas 42.75 33.62 49.50 6 (-13.6%)
Expedia EXPE Online Travel 28.03 19.61 32.89 6 (-14.8%)
Fidelity National Information FIS Payment Services 24.61 22.53 33.76 6 (-27.1%)
HCA Holdings HCA Hospitals 24.19 17.03 35.37 6 (-31.6%)
JPMorgan Chase JPM Banking 30.46 27.85 48.36 6 (-37.0%)
Life Technologies LIFE Medical Products 39.17 35.30 57.25 6 (-31.6%)
Microsoft MSFT Computer Software/Services 25.28 23.65 29.46 6 (-14.2%)
Qualcomm QCOM Wireless Technology 54.73 45.98 59.84 6 (-8.5%)
Six or more SuperInvestors held stakes in these companies as of the end of 2011’s third quarter.Banks – Citigroup, Wells Fargo and JPMorgan Chase – are proving to be particular dead weights onportfolios. Newcomers to the list: BP, Expedia, Fidelity National Information and Life Technologies.
What They Own:Wisdom of Crowds
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
7/10
SuperInvestor Insight 7December 2, 2011 www.superinvestorinsight.com
September 30. Scout Capital's Adam
Weiss at the October Value Investing
Congress argued that the market was mis-
pricing Williams’ component natural gas
pipeline, midstream and exploration and
production businesses, in part due to
uncertainty around the spinoff of its E&P
business now planned for December 31.
The stock at a recent $32.40 is up 33%
since the end of the quarter, compared
with Scout's October base-case estimate
of $37 and its upside case of $47-50.
Still facing large and uncertain costs
from its Gulf of Mexico spill, BP has been
active in managing its portfolio of oil and
gas assets, targeting a total of $30 billion
in asset sales by year end and another $15
billion next year. The company generates
significant cash flow, but one key area of uncertainty is its ability to increase global
production and reserves, especially in
light of partnership squabbles in Russia,
which accounts for 25% of the firm's
annual production. Six top investors
appear to believe such uncertainty is cre-
ating opportunity in the shares – notably,
Baupost Group nearly tripled its BP stake
last quarter, making it the firm's largest
equity position (see table below).
In addition to BP, online travel compa-
ny Expedia, bank IT-services provider
Fidelity National Information and med-
ical-technology firm Life Technologies
were newcomers to the most-owned list
last quarter. Life Technologies sells con-
sumables and instruments used in aca-
demic, governmental and commercial
medical research. Well regarded for its
strong patent portfolio, diversified prod-
uct lines and recurring revenues – 80% of
sales are in branded consumables – the
company has not been immune to gener-al economic worries and fears of industry
price pressures, which since August have
helped send the share price below $40
after it spent much of the year between
$50 and $55. Apparently taking a longer
view are six SuperInvestors, three o
whom established brand-new positions in
the stock last quarter.
In addition to it being the most-owned
stock among star investors at the end o
the quarter, Apple – which had not ye
lost its chairman, Steve Jobs – was also
the largest individual holding of three o
them, Lone Pine, Greenlight and Blue
Ridge. Also the biggest holding of more
than one investor at September 30
Motorola Solutions, the spinoff o
Motorola, Inc. that is not being pur-
chased by Google (that would be
Motorola Mobility). For what it's worth
while both investors – Icahn and
ValueAct – have been relatively quiet to
date, both are well-known in the industryfor their activism.
Funds co-managed by Whitney Tilson are long
C, JCP, JPM, MSFT and WFC.
SII
W HAT T HE Y OW N
Company Ticker IndustryPrice@12/1/11
52-Week Investor
Price vs.52-Week HighLow High
Coca-Cola KO Beverages 66.83 61.29 71.77 Berkshire Hathaway (-6.9%)
SPDR Gold Trust GLD Gold ETF 169.63 127.80 185.85 Paulson (-8.7%)
AutoZone AZO Automotive Parts/Supply 335.30 246.26 341.89 Lampert (-1.9%)
Motorola Solutions MSI Communications Devices 46.41 32.15 47.91 Icahn (-3.1%)
J.C. Penney JCP Department Stores 32.22 23.44 41.00 Pershing Square (-21.4%)
Motorola Solutions MSI Communications Devices 46.41 32.15 47.91 ValueAct (-3.1%)
Apple AAPL Computers/Consumer Electronics 387.93 310.50 426.70 Lone Pine (-9.1%)
Yahoo YHOO Internet Services 16.23 11.09 18.84 Third Point (-13.9%)
U.S. Bancorp USB Banking 25.70 20.10 28.94 Viking (-11.2%)
SLM Corp. SLM Student Lending 12.72 10.91 17.11 Highfields (-25.7%)
Life Technologies LIFE Medical Products 39.17 35.30 57.25 Glenview (-31.6%)
Apple AAPL Computers/Consumer Electronics 387.93 310.50 426.70 Greenlight (-9.1%)
BP BP Oil & Gas 42.75 33.62 49.50 Baupost (-13.6%)
CVS Caremark CVS Pharmacy Services 38.48 31.30 39.50 Relational (-2.6%)
Apple AAPL Computers/Consumer Electronics 387.93 310.50 426.70 Blue Ridge (-9.1%)
These are the 15 largest holdings of different individual SuperInvestors as of the end of third quarter.Three investors made Apple their top holding, while two – activists ValueAct and Icahn – see greatvalue in Motorola Solutions. At the biggest discount to its 52-week high: Life Technologies.
What They Own:Top Holdings
Sources: Forms 13F filed with the Securities and Exchange Commission for holdings as of September 30, 2011.
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
8/10
SuperInvestor Insight 8December 2, 2011 www.superinvestorinsight.com
Walking the TightropeWhile most investors have been focused on avoiding risks in highly leveraged companies, SuperInvestors’ inter-
est in hospital operator HCA Holdings last quarter would indicate they remember leverage can work both ways.
When asked about lessons learned
from 2008's financial crisis, most
investors report having had reiterated to
them the dangers of debt leverage, the
analysis of which is now top-of-mind and
the tolerance for which is currently quite
low. So it comes as a surprise that among
the companies most actively bought by
SuperInvestors in the third quarter was
HCA Holdings, the largest private hospi-
tal owner and operator in the U.S.
Having been taken private in 2006 in a$33 billion LBO by investors including
Bain Capital, KKR and the founding Frist
family, HCA returned to public markets
in March with an IPO priced at $30. The
company is widely regarded as the class
of the hospital-management industry –
maybe not the most ringing accolade
given that three-quarters of the industry
remains in the hands of non-profits – and
it had improved its performance while
private through cost cutting, the sale of
under-performing assets and a focus onhigher-margin outpatient services. Its
EBITDA margin, averaging in the mid-
teens prior to the LBO, hit 19% in 2010.
Debt, however, remains an issue. Even
after raising equity capital in the IPO,
HCA has a negative book value and a
debt/capital ratio of only 1.3x, says
Morningstar analyst Michael Waterhouse.
Given that one-third of adjusted annual
EBITDA goes toward the company's $2
billion annual interest expense tab and
that the remainder narrowly covers neces-sary capital spending, he says, “We think
HCA is walking a bit of a tightrope.”
But when HCA shares got slammed
over the summer due to general economic
fears and increased Washington rhetoric
about healthcare-spending cutbacks – the
stock fell 50% from late July to mid-
September – it was the healthcare stock
that attracted the most SuperInvestor buy-
ing interest. Six such investors sharply
increased their HCA positions, three of
which were brand new. The impetus,
explains the portfolio manager of one of
the new buyers (who asked not to be
quoted by name): “We were basically
looking among the healthcare wreckage to
see what good was being thrown out with
the bad, and HCA stood out for how
cheap it was relative to what we consid-
ered to be a pretty dire recession case.”
The stability in HCA's business out
look comes from the nature of hospita
patient demand, which isn't significantly
influenced by economic ups and downs
from scale cost advantages the company
uses to defend the 20-30% market shares
it typically has in its mostly urban mar
kets, and from the positive demographic
tailwind it enjoys from aging population
S T O CK S P O TL I G HT: H C A H O L D IN G S
HCA Holdings(NYSE: HCA)
Business: Largest hospital owner andoperator in the United States, providingroughly 4% of all domestic inpatient carethrough some 270 facilities in 20 states.
Share Information
(@12/1/11):
Price 24.1952-Week Range 17.03 – 35.37Dividend Yield 0.0%Market Cap $10.56 billion
Financials (TTM):
Revenue $31.90 billionOperating Profit Margin 13.1%Net Profit Margin 2.5%
THE BOTTOM LINE
When the market catches a cold today, the leveraged company’s stock is likely tocatch pneumonia. If one believes the general market fears are overblown and that thecompany’s business outlook is relatively stable, the upside in such stocks can be sub-stantial. Witness SuperInvestors’ interest in this hospital operator over the summer.
I N V E S T M E N T S N A P S H O T
HCA PRICE HISTORY
Sources: Company reports, other publicly available information
40
35
30
25
20
15
40
35
30
25
20
152009 2010 2011
Valuation Metrics
(@12/1/11):
HCA S&P 500Trailing P/E 14.6 13.4Forward P/E Est. 7.0 11.7
Largest Institutional Owners
(@9/30/11):
Company % Owned
Bain Capital 20.5%Kohlberg Kravis Roberts 20.0%Glenview Capital 1.8%
Wellington Mgmt 1.7%Bank of America 1.6%
Short Interest (@11/15/11):
Shares Short/Float 0.5%
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
9/10
SuperInvestor Insight 9December 2, 2011 www.superinvestorinsight.com
S T O C K S P O T L I G H T : H C A H O L D I N G S
in the largely southern states – primarily
Florida and Texas – in which it operates.
The SuperInvestor fund manager says his
firm's recession-case earnings estimate for
HCA is around $3 per share, so he was
able to buy the stock during the third
quarter at just over 6x earnings.
The same stability that provides pro-
tection to the income statement also tem-
pered his concerns about the balance
sheet. “Hospitals can bear a fair amount
of leverage, so that was not troubling,” he
says. “It's also worth pointing out that a
levered equity can recover dramatically if
the fears hitting the stock prove to be
overblown. When the market recovers
10%, the stock can recover 30-40%.”
That's essentially what has happened so
far. At a recent $24.20, HCA shares areup more than 40% from their September
low, during a period in which the market
is up 6%.
The longer-term prognosis for the
stock – which still only trades at 7x Wall
Street's consensus 2012 earnings estimate
– largely rests on one of the tougher ana-
lytical challenges in the market today:
what impact will future healthcare regu-
lation have? The company actually tack-
led the question in a straightforward – if
inconclusive – way in its IPO prospectus:
“We believe the expansion of private-sec-
tor and Medicaid coverage will, over
time, increase our reimbursement relatedto providing services to individuals who
were previously uninsured. On the other
hand, the reductions in the growth in
Medicare payments and the decreases in
Disproportionate Share Hospital pay-
ments will adversely affect our govern-
ment reimbursement. Because of the
many variables involved, including pend
ing court challenges, the potential for
changes to the law as a result and efforts
to amend or repeal the law, we are unable
to predict the net impact of the Health
Reform Law on us.”
Another wildcard is the company’s
ability to restart the acquisition engine
that has fueled its long-term growth. The
hospital industry is expected to continue
to consolidate as a tougher environment
sends struggling non-profits into the
hands of more adept operators like HCA
This could provide the company with
excellent opportunity for accretive
growth – if it can afford it.
Our SuperInvestor's somewhat non
committal take on the stock today
“There's risk that the rules continue to bechanged in ways that hurt HCA, but the
question is whether we believe the stock is
still oversold relative to that exposure
We bought a good company at a good
price. It's been a nice trade, but was prob
ably also a good entry point to a longer
term investment as well.” SII
Expand Your Idea “Grapevine”Gain insight from what superstar investorsown, what they’re buying and whatthey’re selling. Value Investor Insight subscribers receive four quarterly issuesof SuperInvestor Insight for only $149!
Subscribe Online »
Mail-in Form »
Fax-in Form »
Want to learn more?
Please visit www.valueinvestorinsight.com
Or call toll-free:866-988-9060
Expand Your Idea “Grapevine”
ON LEVERAGE:
It’s worth pointing out that a
levered equity can recover
dramatically if the fears hit-
ting the stock are overblown.
http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://www.valueinvestorinsight.com/superinvestorinsighthttp://www.valueinvestorinsight.com/superinvestorinsight/subscribehttp://www.valueinvestorinsight.com/superinvestorinsight/download/SII_MailFormhttp://www.valueinvestorinsight.com/superinvestorinsight/download/SII_FaxFormhttp://www.valueinvestorinsight.com/superinvestorinsighthttp://www.valueinvestorinsight.com/superinvestorinsighthttp://www.valueinvestorinsight.com/superinvestorinsighthttp://www.valueinvestorinsight.com/superinvestorinsight/download/SII_FaxFormhttp://www.valueinvestorinsight.com/superinvestorinsight/download/SII_MailFormhttp://www.valueinvestorinsight.com/superinvestorinsight/subscribehttp://www.valueinvestorinsight.com/superinvestorinsighthttp://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90
-
8/16/2019 SII 2012.12
10/10
SuperInvestor Insight™ is published quarterly at www.superinvestorinsight.com (the “Site”), by Value Investor Media, Inc
Chairman and Co-Editor-in-Chief, Whitney Tilson; President and Co-Editor-in-Chief, John Heins. Annual subscription price: $199
©2011 by Value Investor Media, Inc. All rights reserved. All Site content is protected by U.S. and international copyright laws and
is the property of VIM and any third-party providers of such content. The U.S. Copyright Act imposes liability of up to $150,000
for each act of willful infringement of a copyright.
Subscribers may download Site content to their computer and store and print Site materials for their individual use only. Any
other reproduction, transmission, display or editing of the Content by any means, mechanical or electronic, without the prior
written permission of VIM is strictly prohibited.
Terms of Use:Use of this newsletter and its content is governed by the Site Terms of Use described in detail atwww.valueinvestorinsight.com/misc/termsofuse . For your convenience, a summary of certain key policies, disclosures and disclaimers ireproduced below. This summary is meant in no way to limit or otherwise circumscribe the full scope and effect of the complete Termsof Use.
No Investment Advice
This newsletter is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solic
itation would be illegal. This newsletter is distributed for informational purposes only and should not be construed as investment adviceor a recommendation to sell or buy any security or other investment, or undertake any investment strategy. It does not constitute a gen-
eral or personal recommendation or take into account the particular investment objectives, financ ial situations, or needs of individua
investors. The price and value of securities referred to in this newsletter will fluctuate. Past performance is not a guide to future
performance, future returns are not guaranteed, and a loss of all of the original capital invested in a security discussed in this newslet
ter may occur. Certain transactions, including those involving futures, options, and other derivatives, give rise to substantial risk and are
not suitable for all investors.
Disclaimers
There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth in
this newsletter. Value Investor Media will not be liable to you or anyone else for any loss or injury resulting directly or indirectly from
the use of the information contained in this newsletter, caused in whole or in part by its negligence in compiling, interpreting, reporting
or delivering the content in this newsletter.
Related Persons
Value Investor Media’s officers, directors, employees and/or principals (collectively “Related Persons”) may have positions in and may
from time to time, make purchases or sales of the securities or other investments discussed or evaluated in this newsletter.
Whitney Tilson, Chairman of Value Investor Media, is also a principal of T2 Partners Management, LP, a registered investment adviser
T2 Partners Management, LP may purchase or sell securities and financial instruments discussed in this newsletter on behalf of certain
accounts it manages.
It is the policy of T2 Partners Management, LP and all Related Persons to allow a full trading day to elapse after the publication of thi
newsletter before purchases or sales are made of any security or financial instrument discussed in the Stock Spotlight section herein.
Compensation
Value Investor Media, Inc. receives compensation in connection with the publication of this newsletter only in the form of subscription
fees charged to subscribers and reproduction or re-dissemination fees charged to subscribers or others interested in the newsletter
content.
Contact Information:
For all customer service, subscription or other inquiries, please visit www.superinvestorinsight.com, or contact us at
Value Investor Insight, 2071 Chain Bridge Road, Suite 400, Vienna, VA 22182; telephone: 703-288-9060
SuperInvestor InsighDecember 2, 2011 www.superinvestorinsight.com
G E N E R A L P U B L I C A T I O N I N F O R M AT I O N A N D T E R M S O F U S E
http://www.valueinvestorinsight.com/http://www.valueinvestorinsight.com/misc/termsofusehttp://www.valueinvestorinsight.com/misc/termsofusehttp://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://localhost/var/www/apps/conversion/tmp/scratch_2/%C8%94%EF%BF%90http://www.valueinvestorinsight.com/misc/termsofusehttp://www.valueinvestorinsight.com/